Most Recent
Construction PRO
Damages issue sent back to referee in ‘mega-litigation’ over Ichthys LNG coating
In “mega-litigation” over allegedly defective anti-corrosive coating used on the $45 billion Ichthys natural gas project, a judge has handballed an issue raised by Japanese oil company Inpex about damages calculations back to a referee.
Construction PRO
AkzoNobel wins partial bid for more docs in ‘complex, massive’ Ichthys LNG case
AkzoNobel has had some success in its late bid to have Japanese oil company INPEX produce documents filed in related proceedings against its insurers in their dispute over allegedly defective coating used on the $45 billion Ichthys natural gas project.
High Court to hear appeal in high-stakes stoush over generic Plavix ban
The High Court has agreed to weigh in on a 16-year battle between the federal government and French drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix.
Top class action, commercial barristers among 25 new silks
Twenty-five barristers have joined the rank of silk in NSW, including one who represented AMP in a class action that settled for $100 million and another who is assisting the Commonwealth in its fight to recoup $325 million in excess subsidies in a dispute over generic Plavix.
Government brings $325M High Court challenge over generic Plavix ban
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version of blockbuster blood-thinner Plavix has gone to the High Court.
‘More is more’ approach to pleadings an increasing problem, lawyers say
A Federal Court judge who recently ordered new pleadings in a copyright case against CoreLogic is the latest judge fed up with plaintiffs pleading innumerable alternatives that waste court resources, add to the length of trials and extend the wait time for judgments.
Sanofi defeats government’s $325M appeal over generic Plavix ban
Drug maker Sanofi-Aventis is not liable for the federal government’s losses for excess subsidies paid for the blood-thinner Plavix after an allegedly unjustified court injunction prevented the release of a generic version of the blockbuster drug, an appeals court has found.
Full Court deals drug companies a blow on patent term extensions
The Full Court has upheld two judgments that shortened patent term extensions granted to Merck Sharpe & Dohme and Ono Pharmaceuticals, finding the extension regime cannot be construed as achieving a "commercial outcome for a patentee".
Qantas ordered to pay Perth Airport $9.5M in terminal fee dispute
Qantas has been ordered to pay $9.5 million in unpaid fees after the Western Australia Supreme Court resolved a dispute over the "fair and reasonable" amount owed for terminal services provided for the airline's domestic and international flights.
Fraud cross-claims struck out in Mach Energy suit over Mount Pleasant coal mine
A judge has struck out allegations of fraud in a cross-claim brought by the operator of a NSW open-cut coal mine, which accused several contractors of knowingly understating the time and cost of expansion works to the tune of $52 million.